Morgan Stanley’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-346,223
| Closed | -$1.48M | – | 6948 |
|
|
2019
Q3 | $1.48M | Sell |
346,223
-48,173
| -12% | -$175K | ﹤0.01% | 4041 |
|
|
2019
Q2 | $1.18M | Sell |
394,396
-27,821
| -7% | -$69.7K | ﹤0.01% | 4140 |
|
|
2019
Q1 | $735K | Buy |
422,217
+21,289
| +5% | +$29.4K | ﹤0.01% | 4320 |
|
|
2018
Q4 | $337K | Buy |
400,928
+100,934
| +34% | +$120K | ﹤0.01% | 5041 |
|
|
2018
Q3 | $426K | Buy |
299,994
+46,582
| +18% | +$51K | ﹤0.01% | 5085 |
|
|
2018
Q2 | $209K | Buy |
253,412
+35,879
| +16% | +$34.6K | ﹤0.01% | 5516 |
|
|
2018
Q1 | $298K | Sell |
217,533
-2,154
| -1% | -$2.5K | ﹤0.01% | 5282 |
|
|
2017
Q4 | $222K | Buy |
219,687
+81,919
| +59% | +$92.7K | ﹤0.01% | 5370 |
|
|
2017
Q3 | $209K | Buy |
137,768
+59,902
| +77% | +$100K | ﹤0.01% | 5334 |
|
|
2017
Q2 | $145K | Sell |
77,866
-419,157
| -84% | -$558K | ﹤0.01% | 5488 |
|
|
2017
Q1 | $651K | Sell |
497,023
-1,874,097
| -79% | -$1.53M | ﹤0.01% | 4675 |
|
|
2016
Q4 | $1.66M | Buy |
2,371,120
+2,361,068
| +23,489% | +$1.99M | ﹤0.01% | 4086 |
|
|
2016
Q3 | $11K | Buy |
+10,052
| New | +$13.4K | ﹤0.01% | 6100 |
|
|
2016
Q2 | – | Sell |
-10,550
| Closed | -$10K | – | 6763 |
|
|
2016
Q1 | $10K | Buy |
10,550
+7,577
| +255% | +$13K | ﹤0.01% | 6145 |
|
|
2015
Q4 | $10K | Buy |
2,973
+473
| +19% | +$1.48K | ﹤0.01% | 6250 |
|
|
2015
Q3 | $8K | Sell |
2,500
-289
| -10% | -$1.04K | ﹤0.01% | 6310 |
|
|
2015
Q2 | $10K | Buy |
+2,789
| New | +$11.9K | ﹤0.01% | 6302 |
|
Morgan Stanley's CVRS Position: Q4 2019 in Review
Morgan Stanley sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 346,223 shares — an estimated $1.48M sold.
Morgan Stanley first reported a position in CVRS in Q2 2015 and held it in 17 quarters. The position peaked at $1.66M in Q4 2016. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Morgan Stanley reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Morgan Stanley sold 346,223 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $1.48M.
- Morgan Stanley first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 17 quarters.
- Morgan Stanley's CORINDUS VASCULAR ROBOTICS, INC position peaked at $1.66M in Q4 2016.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.